Stryker moved 0.1% this afternoon session, trading between a high of $294.2 and a low of $291.2 per share. Yesterday the stock finished at $293.22 per share, compared to an average analyst target price of $321.57.
Stryker Corporation operates as a medical technology company. The large-cap medical/dental instruments company is based in the United States, and over the last twelve months it has returned a dividend yield of 1.0%. Stryker has trailing twelve months earnings per share (EPS) of 7.09, which at today's prices amounts to a price to earnings (P/E) ratio of 41.4.
Based on its expected future earnings growth, the company has a price to earnings growth (PEG) ratio of 2.81. Usually a PEG ratio between 0 and 1 indicates a potentially undervalued company.
Overview of the Company's Gross Margins:
| Date Reported | Revenue ($ k) | Cost of Revenue ($ k) | Gross Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-10 | 18,449,000 | -6,871,000 | 63 | -1.56 |
| 2022-02-11 | 17,108,000 | -6,140,000 | 64 | 1.59 |
| 2021-02-11 | 14,351,000 | -5,294,000 | 63 | -3.08 |
| 2020-02-06 | 14,884,000 | -5,188,000 | 65 | -1.52 |
| 2019-02-07 | 13,601,000 | -4,663,000 | 66 | 0.0 |
| 2018-02-08 | 12,444,000 | -4,264,000 | 66 |
At 64.5%, Stryker's average gross margins are wider than the 57.74% average of its industry peer group, which suggests that the firm might have a competitive advantage.
